2011 Annual Meeting & Associated Programs
Join us November 3-6, 2011 in North Bethesda, MD for our 26th Annual Meeting and Associated Programs for scientific exchange of the most cutting-edge preclinical and clinical data on immunotherapies and biological therapy of cancer!
Abstract Submission & Registration
Opens May 2, 2011!
Opens May 2, 2011!
Download a copy of the Save the Date PowerPoint Slide for your use in promoting the 2011 Annual Meeting & Associated Programs. Click on the above image to download.
This annual event has become known as the premier venue for interaction, innovation and education in cancer immunotherapy. Please follow the links below for more information on each exciting program.
“…the only meeting of its kind where physician clinical investigators are side by side PHD scientists whether in a lecture or beside a poster presentation discussing their work and providing the truest opportunities for education, collaboration, and translation.”
– F. Stephen Hodi, MD
Dana-Farber Cancer Institute
26th Annual Meeting
November 4-6, 2011
Bethesda North Marriott Hotel & Conference Center
North Bethesda, Maryland
Ralph M. Steinman, MD
The Rockefeller University
Dr. Steinman, co-discoverer of dendritic cells, will deliver the Richard V. Smalley, MD, Memorial Lectureship at the 26th Annual Meeting. Dr. Steinman’s opening keynote address Friday 8:00 am, November 4, 2011 will be followed by a plenary session on “Biology & Application of Dendritic Cells.”
Organizers
Charles G. Drake, MD, PhD – Johns Hopkins University
Dolores J. Schendel, PhD – Helmholtz Zentrum Muenchen – German Research Center for Environmental Health Institute of Molecular Immunology
Jeffrey Schlom, PhD – National Cancer Institute, National Institutes of Health
Jedd D. Wolchok, MD, PhD – Memorial Sloan-Kettering Cancer Center
- Biology & Application of Dendritic Cells
- Immunology of Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)
- Uncoupling Negative Regulation in the Tumor Microenvironment
- Genetically Engineered Receptors and Adoptive Cell Therapies
- Characterization of Inflammatory Infiltrates in Human Cancers
- State of the Art Animal Models and Veterinary Applications for Cancer and Immunology
- High Throughput Technologies for Immune Monitoring
- Prostate Cancer as a Learning Model
Additional poster-only topics will include therapeutic monoclonal antibodies in cancer, immunotherapy combinations, innate immunity in cancer, tumor vasculature, chemokines and lymphocyte trafficking to the tumor, and targeted therapies and anti-tumor immunity.
Workshop on Immunotherapy Combinations in Cancer
November 3, 2011
Bethesda North Marriott Hotel & Conference Center
North Bethesda, Maryland
Organizers
Alan J. Korman, PhD – Bristol-Myers Squibb
Ignacio Melero, MD, PhD – University of Navarra
Hideho Okada, MD, PhD – University of Pittsburgh Cancer Institute
Suzanne L. Topalian, MD – Johns Hopkins University School of Medicine
- Immunotherapy Combination with Other Immunotherapies
- Immunotherapy Combinations with Conventional Cancer Therapies
- Logistical Issues: Regulatory, Legal, Industry and Academic Perspectives
- Clinical Trial Efforts – What Have We Learned?
Primer on Tumor Immunology and Cancer Immunotherapy
November 3, 2011
Bethesda North Marriott Hotel & Conference Center
North Bethesda, Maryland
Organizers
Walter J. Urba, MD, PhD – Earle A. Chiles Research Institute
Mario Sznol, MD – Yale Cancer Center
- Innate Immunity
- Dendritic Cells
- T Cell Differentiation: From Naïve to Effector Cells
- T Cell Intracellular Signaling
- Immunobiology of the Tumor Microenvironment
- Tumor Antigen, Tumor Immunogenicity and Immunization
- Coinhibition / Costimulation
- Adoptive Immunotherapy
- Immune Monitoring
Published Summaries of Biomarkers Symposium and Primer Now Available
The Journal of Translational Medicine has recently published proceedings of the Symposium on Immuno-Oncology Biomarkers, 2010 and Beyond: Perspectives from the iSBTc Biomarker Task Force, which took place on September 30, 2010 at the NIH, as well as a detailed summary of the Primer on Tumor Immunology and Biological Therapy of Cancer, which took place October 1, 2010 in Washington, D.C. These publications may be downloaded free of charge from our website.
| Biomarkers Symposium Summary | Primer Summary |
New NCI Project to Drive Cancer Research Progress
The NCI recently launched a novel project to identify provocative questions and perplexing problems to drive progress in cancer research. This project may serve as a useful means to present important questions and hurdles to advancing cancer immunotherapy to NCI leadership and to colleagues involved in other areas of cancer research. Log in directly to submit a question.
How Did We Do? Give Us Your Feedback!
Did you attend an iSBTc/SITC program in 2010? If you so, we would appreciate your feedback. If you haven’t already, please take a few moments to complete a short survey about our 2010 Annual Meeting and Associated Programs to help us in planning future programs. Thank you!
| Survey |
2011 Membership Dues
Members - Keep the Benefits Coming!
It's that time of year again to renew your dues for 2011! Simply click on the green "Pay Dues Online" button, log in to your account and click on "Renew My Dues" in the Members Only section.
Interested in becoming a member of the Society for Immunotherapy of Cancer? There are numerous benefits. Join now and become a part of our Society of leading-edge professionals in the field of cancer immunotherapy and biological therapy.
| ONLINE MEMBERSHIP APPLICATION |